Soleo Health has developed limited distribution networks by leveraging SoleMetrics ability to collect and deliver real-world, insightful data regarding a drug’s clinical capabilities, derived from its patients
Maxor Specialty Pharmacy has a focus on pulmonary disease
Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]
How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]
Onco360 recently announced that it has been selected to be part of the limited network to distribute Gilead Sciences’ Zydelig (idelalisib) tablets. Onco360 is one of the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services companies. It will now be part of the highly limited Specialty Pharmacy network of Zydelig tablets, which has just […]